Immunophenotypic analysis of cerebrospinal fluid reveals concurrent development of ATL in the CNS of a HAM/TSP patient.


Journal

International journal of hematology
ISSN: 1865-3774
Titre abrégé: Int J Hematol
Pays: Japan
ID NLM: 9111627

Informations de publication

Date de publication:
Jun 2020
Historique:
received: 09 09 2019
accepted: 26 12 2019
revised: 26 12 2019
pubmed: 14 1 2020
medline: 30 9 2020
entrez: 14 1 2020
Statut: ppublish

Résumé

Both adult T-cell leukemia/lymphoma (ATL) and human T-cell leukemia virus type 1 (HTLV-1)-associated myelopathy/tropical spastic paraparesis (HAM/TSP) can be induced by HTLV-1, but concurrent development has been rarely reported. We present the case of a 55-year-old female who developed cranial nerve symptoms after a 20-year history of HAM/TSP. Although multiple white matter lesions were observed on brain magnetic resonance imaging, no abnormalities were seen on a systemic computed tomography scan. Quantitative flow-cytometric analysis of cell populations in the cerebrospinal fluid (CSF) revealed that most of the infiltrating cells were not inflammatory cells, but HTLV-1-infected CD4

Identifiants

pubmed: 31930455
doi: 10.1007/s12185-019-02815-7
pii: 10.1007/s12185-019-02815-7
pmc: PMC7222977
doi:

Substances chimiques

Antigens, CD7 0

Types de publication

Case Reports Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

891-896

Références

Cancer Sci. 2015 May;106(5):598-603
pubmed: 25703103
PLoS Negl Trop Dis. 2013 Oct 10;7(10):e2479
pubmed: 24130912
Clin Cancer Res. 2014 Jun 1;20(11):2851-61
pubmed: 24727323
AJNR Am J Neuroradiol. 2011 Jun-Jul;32(6):984-92
pubmed: 20616176
PLoS One. 2013;8(1):e53728
pubmed: 23349737
Front Microbiol. 2012 Nov 09;3:389
pubmed: 23162542
Leuk Lymphoma. 1995 Nov;19(5-6):437-45
pubmed: 8590844
Leuk Res Treatment. 2012;2012:101754
pubmed: 23259064
Front Microbiol. 2018 Jul 25;9:1651
pubmed: 30090093
Br J Haematol. 2005 Aug;130(4):511-5
pubmed: 16098064
Cancer Sci. 2019 Dec;110(12):3746-3753
pubmed: 31642546
Viruses. 2011 Sep;3(9):1532-48
pubmed: 21994794
Br J Haematol. 1991 Nov;79(3):428-37
pubmed: 1751370
Neuroradiology. 2002 Jul;44(7):559-67
pubmed: 12136356
Int J Cell Biol. 2015;2015:813216
pubmed: 26664363
Front Microbiol. 2012 Nov 15;3:388
pubmed: 23162541
Br J Haematol. 2018 Aug;182(3):384-403
pubmed: 29808930
J Clin Invest. 2014 Aug;124(8):3431-42
pubmed: 24960164
JAMA Neurol. 2013 Mar 1;70(3):311-9
pubmed: 23319132
Intern Med. 1995 Nov;34(11):1130-3
pubmed: 8774979
Cancer Sci. 2017 Dec;108(12):2478-2486
pubmed: 28905463

Auteurs

Reina Takeda (R)

Department of Hematology/Oncology, Research Hospital, The Institute of Medical Science, The University of Tokyo, 4-6-1 Shirokanedai, Minato-ku, Tokyo, 108-8639, Japan.

Tomohiro Ishigaki (T)

Department of Hematology/Oncology, Research Hospital, The Institute of Medical Science, The University of Tokyo, 4-6-1 Shirokanedai, Minato-ku, Tokyo, 108-8639, Japan. ishigaki@ims.u-tokyo.ac.jp.
Department of Laboratory Medicine, Research Hospital, Institute of Medical Science, The University of Tokyo, Tokyo, Japan. ishigaki@ims.u-tokyo.ac.jp.

Nobuhiro Ohno (N)

Department of Hematology/Oncology, Research Hospital, The Institute of Medical Science, The University of Tokyo, 4-6-1 Shirokanedai, Minato-ku, Tokyo, 108-8639, Japan.
Division of Molecular Therapy, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan.

Kazuaki Yokoyama (K)

Department of Hematology/Oncology, Research Hospital, The Institute of Medical Science, The University of Tokyo, 4-6-1 Shirokanedai, Minato-ku, Tokyo, 108-8639, Japan.

Toyotaka Kawamata (T)

Department of Hematology/Oncology, Research Hospital, The Institute of Medical Science, The University of Tokyo, 4-6-1 Shirokanedai, Minato-ku, Tokyo, 108-8639, Japan.
Division of Molecular Therapy, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan.

Tomofusa Fukuyama (T)

Department of Hematology/Oncology, Research Hospital, The Institute of Medical Science, The University of Tokyo, 4-6-1 Shirokanedai, Minato-ku, Tokyo, 108-8639, Japan.
Division of Cellular Therapy, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan.

Natsumi Araya (N)

Department of Rare Diseases Research, Institute of Medical Science, St. Marianna University School of Medicine, Kawasaki, Kanagawa, Japan.

Yoshihisa Yamano (Y)

Department of Rare Diseases Research, Institute of Medical Science, St. Marianna University School of Medicine, Kawasaki, Kanagawa, Japan.

Kaoru Uchimaru (K)

Department of Hematology/Oncology, Research Hospital, The Institute of Medical Science, The University of Tokyo, 4-6-1 Shirokanedai, Minato-ku, Tokyo, 108-8639, Japan.
Laboratory of Tumor Cell Biology, Department of Computational Biology and Medical Science, Graduate School of Frontier Sciences, The University of Tokyo, Tokyo, Japan.

Arinobu Tojo (A)

Department of Hematology/Oncology, Research Hospital, The Institute of Medical Science, The University of Tokyo, 4-6-1 Shirokanedai, Minato-ku, Tokyo, 108-8639, Japan.
Department of Laboratory Medicine, Research Hospital, Institute of Medical Science, The University of Tokyo, Tokyo, Japan.
Division of Molecular Therapy, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH